Last reviewed · How we verify
Injectafer
At a glance
| Generic name | Injectafer |
|---|---|
| Also known as | ferric carboxymaltose injection, Ferric Carboxymaltose (FCM), Ferinject®, Iroprem®, Renegy® |
| Sponsor | United States Army Research Institute of Environmental Medicine |
| Modality | Small molecule |
| Therapeutic area | Hematology |
| Phase | FDA-approved |
Approved indications
- Iron deficiency anemia
Common side effects
- Nausea
- Hypertension
- Flushing
- Injection site reactions
- Erythema
- Dizziness
- Vomiting
- Injection Site Discoloration
- Headache
- Hepatic enzyme increased
- Dysgeusia
- Hypotension
Serious adverse events
- Hypertensive crisis
- Injection site extravasation
- Erythema multiforme
Key clinical trials
- Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome (PHASE4)
- The Role of Ferric Carboxymaltose in the Treatment of Pediatric Iron Deficiency Anemia in the Emergency Department (PHASE4)
- EFFICACY OF IV VERSUS ORAL IRON IN THE TREATMENT OF IRON DEFICIENCY ANEMIA DURING PREGNANCY (PHASE1)
- The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary Hypertension (PHASE4)
- Iron Infusion in Patients Undergoing Transcatheter Aortic Valve Implantation (PHASE4)
- Comparison of Oral vs Intravenous Iron Therapy for the Treatment of Postpartum Anemia (NA)
- Postoperative i.v. Iron Substitution in Patients With Diagnosed Iron Deficiency (PHASE3)
- An Open Study on the Efficacy of Iron Therapy Using iv Iron Relative to Oral Iron for Increasing LV Systolic Function (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Injectafer CI brief — competitive landscape report
- Injectafer updates RSS · CI watch RSS
- United States Army Research Institute of Environmental Medicine portfolio CI